Retraction: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites.
RSC Adv
; 14(3): 1625, 2024 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-38179089
ABSTRACT
[This retracts the article DOI 10.1039/C9RA10593J.].
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
RSC Adv
Year:
2024
Document type:
Article
Country of publication: